Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sunbed use legislation in Europe: assessment of current status.
Longo MI, Bulliard JL, Correia O, Maier H, Magnússon SM, Konno P, Goad N, Duarte AF, Oláh J, Nilsen LTN, Peris K, Karls R, Forsea AM, Del Marmol V. Longo MI, et al. Among authors: konno p. J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:89-96. doi: 10.1111/jdv.15317. J Eur Acad Dermatol Venereol. 2019. PMID: 30811694
The journey of patients with skin diseases from the first consultation to the diagnosis in a representative sample of the European general population from the EADV burden of skin diseases study.
Richard MA, Paul C, Nijsten T, Gisondi P, Salavastru C, Taieb C, Stratigos A, Trakatelli M, Puig L; EADV Burden of Skin Diseases Project Team. Richard MA, et al. J Eur Acad Dermatol Venereol. 2023 Oct;37 Suppl 7:17-24. doi: 10.1111/jdv.18916. J Eur Acad Dermatol Venereol. 2023. PMID: 37806003
Waardenburg syndrome.
Konno P, Silm H. Konno P, et al. J Eur Acad Dermatol Venereol. 2001 Jul;15(4):330-3. J Eur Acad Dermatol Venereol. 2001. PMID: 11730045
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study.
Papp KA, Langley RG, Sigurgeirsson B, Abe M, Baker DR, Konno P, Haemmerle S, Thurston HJ, Papavassilis C, Richards HB. Papp KA, et al. Among authors: konno p. Br J Dermatol. 2013 Feb;168(2):412-21. doi: 10.1111/bjd.12110. Epub 2013 Jan 18. Br J Dermatol. 2013. PMID: 23106107 Clinical Trial.
Prevalence and determinants of sunbed use in thirty European countries: data from the Euromelanoma skin cancer prevention campaign.
Suppa M, Gandini S, Njimi H, Bulliard JL, Correia O, Duarte AF, Peris K, Stratigos AJ, Nagore E, Longo MI, Bylaite-Bucinskiene M, Karls R, Helppikangas H; Euromelanoma Working Group,; Del Marmol V. Suppa M, et al. J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:13-27. doi: 10.1111/jdv.15311. J Eur Acad Dermatol Venereol. 2019. PMID: 30811698
Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaign.
Suppa M, Gandini S, Njimi H, Bulliard JL, Correia O, Duarte AF, Peris K, Stratigos AJ, Nagore E, Longo MI, Bylaite-Bucinskiene M, Karls R, Helppikangas H; Euromelanoma Working Group,; Del Marmol V. Suppa M, et al. J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:76-88. doi: 10.1111/jdv.15307. J Eur Acad Dermatol Venereol. 2019. PMID: 30811689
12 results